Antibasal ganglia antibodies and antistreptolysin o in noncomorbid ADHD

Journal of Attention Disorders

Volumn 19, Issue 11, 2015, Pages 965-970

  Toto, Maddalena ^a   Margari, Francesco ^a   Simone, Marta ^a   Craig, Francesco ^a   Petruzzelli, Maria Giuseppina ^a   Tafuri, Silvio ^a   Margari, Lucia ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

ADHD; Antibasal ganglia antibodies; Antistreptolysin O

Indexed keywords

ANTISTREPTOLYSIN; AUTOANTIBODY; BACTERIUM ANTIBODY; BIOLOGICAL MARKER; IMMUNOLOGIC FACTOR;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BASAL GANGLION; BLOOD; CHILD; FEMALE; HUMAN; IMMUNOLOGY; MALE; MICROBIOLOGY; PRESCHOOL CHILD; PREVALENCE; STREPTOCOCCAL INFECTIONS;

ADOLESCENT; ANTIBODIES, BACTERIAL; ANTISTREPTOLYSIN; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTOANTIBODIES; BASAL GANGLIA; BIOMARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; PREVALENCE; STREPTOCOCCAL INFECTIONS;

EID: 84943522134     PISSN: 10870547     EISSN: 15571246     Source Type: Journal    
DOI: 10.1177/1087054712455505     Document Type: Article

References (40)

1. Alexander, G. E., Delong, M. R., & Strick, P. L. (1986). Parallel organization of functionally segregated circuit linking basal ganglia and cortex. Annual Review of Neuroscience, 9, 357-381.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
4. Church, A. J., Cardoso, F., Dale, R. C., Lees, A. J., Thompson, E. J., & Giovannoni, G. E. J. (2002). Anti-basal ganglia antibodies in acute and persistent Sydenham’s chorea. Neurology, 59, 227-231.
5. Church, A. J., Dale, R. C., Cardoso, F., Candler, P. M., Chapman, M. D., Allen, M. L., Giovannoni, G. (2003). CSF and serum immune parameters in Sydenham’s chorea: Evidence of an autoimmune syndrome? Journal of Neuroimmunology, 136, 149-153.
6. Church, A. J., Dale, R. C., & Giovannoni, G. (2004). Anti-basal ganglia antibodies: A possible diagnostic utility in idiopathic movement disorders? Archives of Disease in Childhood, 89, 611-614.
7. Commission on Classification and Terminology of the International League Against Epilepsy (1989). Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30, 389-399.
8. Dale, R. C. (2005). Post-streptococcal autoimmune disorders of the central nervous system. Developmental Medicine and Child Neurology, 47,785-791.
9. Dale, R. C., Candler, P. M., Church, A. J., Wait, R., Popock, J. M., & Giovannoni, G. (2006). Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. Journal of Neuroimmunology, 172, 187-197.
10. Dale, R. C., Church, A. J., Surtees, R. A., Lees, A. J., Adcock, J. E., Marding, B., Giovannoni, G. (2004). Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain, 127, 21-33.
11. Haber, S. N. (2003). The primate basal ganglia: Parallel and integrative networks. Journal of Chemical Neuroanatomy, 26, 317-330.
12. Hallett, J., Harling-Berg, C. J., Knopf, P. M., Stopa, E. G., & Kiessling, L. S. (2000). Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. Journal of Neuroimmunology, 111, 195-202.
13. Headache Classification Subcommittee of the International Headache Society (2004). The International Classification of Headache Disorders, 2nd edn. Cephalalgia, 24,1-160.
14. Hoffman, K. L., Horing, M., Yaddonapudi, I. C., Jabado, O., & Lipkin, W. I. (2004). A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection. Journal of Neuroscience, 24, 1780-1791.
15. Jensen, P. S. (2000). Attention-deficit/hyperactivity disorder: Concepts on etiology, pathophysiology and neurobiology. Child and Adolescent Psychiatric Clinics of North America, 9, 557-572.
16. Kaplan, E. L., Rothermel, C. D., & Johnson, D. R. (1998). Antistreptolysin O and anti deoxyribonuclease B titers: Normal values for children ages 2 to 12 in the U.S.A. Pediatrics, 101, 86-88.
17. Kiessling, L. S., Marcotte, A. C., & Culpepper, L. (1993). Antineural antibodies in movement disorder. Pediatrics, 92, 39-43.
18. Kirvan, C. A., Swedo, S. E., Heuser, J. S., & Cunnigham, M. W. (2003). Mimicry and autoantibody-mediated neuronal cell signalling in Sydenham’s chorea. Nature Medicine, 9, 914-920.
19. Kurlan, R. (2001). Could Tourette syndrome be a neurologic manifestation of rheumatic fever? Advances in Neurology, 85, 307-310.
20. Kurlan, R., Johnson, D., Kaplan, E. L., & The Tourette Syndrome Study Group. (2008). Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: A prospective blinded cohort study. Pediatrics, 121, 1188-1197.
21. Leslie, D. L., Kozma, L., Martin, A., Landeros, A., Katsovich, L., King, R. A., & Leckman, J. F. (2008). Neuropsychiatric disorders associated with Streptococcal infection: A case-control study among privately insured children. Journal of the American Academy of Child & Adolescent Psychiatry, 47, 1166-1172. doi:10.1097/CHI
22. Loiselle, C. R., Wendlandt, J. T., Rohde, C. A., & Singer, H. S. (2003). Antistreptococcal, neuronal, and nuclear antibodies in Tourette syndrome. Pediatric Neurology, 28, 119-125.
23. Lou, H. C., Andersen, J., Steinberg, B., McLauglin, T., & Friberg, L. (1998). The striatum in a putative cerebral network activated by verbal awareness in normal and ADHD children. European Journal of Neurology, 5, 67-74.
24. Margari, L., Ventura, P., Portoghese, C., Presicci, A., Buttiglione, M., & Di Cuonzo, F. (2006). Brain magnetic resonance spectroscopy in Sydenham’s chorea and ADHD. Pediatric Neurology, 34, 467-473.
25. Martino, D., Church, A. J., & Defazio, G. (2005). Soluble adhesion molecules in Gilles de la Tourette’s syndrome. Journal of the Neurological Sciences, 234, 79-85.
26. Martino, D., Defazio, G., Church, A. J., Russell, C., Dale, R. C., Giovannoni, G., Orth, M. (2007). Antineuronal antibody status and phenotype analysis in Tourette’s syndrome. Movement Disorders, 22, 1424-1429.
27. Mercadante, M. T., Hounie, A. G., Diniz, J. B., Miguel, E. C., & Lombroso, P. J. (2001). The basal ganglia and immune-based neuropsychiatric disorders. Psychiatric Annals, 31, 534-540.
28. Mink, J. W. (2001). Basal ganglia dysfunction in Tourette’s syndrome: A new hypothesis. Pediatric Neurology, 25, 190-198.
29. Morshed, S. A., Parveen, S., Leckman, J. F., Mercadante, M. T., Bittencourt Kiss, M. H., Miguel, E. C., Lombroso, P. J. (2001). Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette syndrome, Sydenham’s chorea and autoimmune disorders. Biological Psychiatry, 50, 566-577.
30. Muller, N., Riedel, M., Straube, A., Gunther, W., & Wilske, B. (2000). Increased anti-streptococcal antibodies in patients with Tourette’s syndrome. Psychiatry Research, 94, 43-49.
31. Peterson, B. S., Leekman, J. F., Tucker, D., Scahill, L., Staib, L., Zhang, H., Lombroso, P. (2000). Preliminary finding of streptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit/hyperactivity disorders. Archives of General Psychiatry, 57, 364-372.
32. Polanczyk, G., de Lima, M. S., Horta, B., Biederman, J., & Rohde, L. A. (2007). The Worldwide prevalence of ADHD: A systematic review and metaregression analysis. American Journal of Psychiatry, 164, 942-948.
33. Sanchez-Carpintero, R., Albesa, S. A., Crespo, N., Villoslada, P., & Narbona, J. (2009). A preliminary study of the frequency of anti-basal ganglia antibodies and streptococcal infection in attention deficit/hyperactivity disorder. Journal of Neurology, 256, 1103-1108.
34. Sheppard, D. M., Bradshaw, J. L., Purcell, R., & Pantelis, C. (1999). Tourette’s and comorbid syndromes: Obsessive compulsive and attention deficit hyperactivity disorder. A common etiology? Clinical Psychology Review, 19, 531-552.
35. Singer, H. S., Giuliano, J. D., Hansen, B. H., Laurino, J. P., Benson, M., & Kiessling, L. S. (1998). Antibodies against human putamen in children with Tourette syndrome. Neurology, 50, 1618-1624.
36. Swanson, J. M., Sergeant, J. A., Taylor, E., Sonuga-Barke, E. J. S., Jensen, P. S., & Cantwell, D. P. (1998). Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet, 351, 429-433.
37. Swedo, S. E. (1994). Sydenham’s chorea: A model for childhood autoimmune neuropsychiatric disorder. Journal of the American Medical Association, 272, 1788-1791.
38. Swedo, S. E., Leonard, H. L., Garvey, M., Mittleman, B., Allen, A. J., Perlmutter, S., Dubbert, B. K. (1998). Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection: Clinical description of the first 50 cases. American Journal of Psychiatry, 155, 264-271.
39. Tannock, R. (1998). Attention deficit hyperactivity disorder: Advance in cognitive, neurobiological, and genetic research. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 39, 65-99.
40. Teixeira, A. L., Jr., Cardoso, F., Souza, A. L., & Teixeira, M. M. (2004). Increased serum concentrations of monokine induced by interferon-gamma/CXCL9 and interferon-gamma-inducible protein 10/CXCL-10 in Sydenham’s chorea patients. Journal of Neuroimmunology, 150, 157-162.